MedPath

A clinical trial to study the effect of Saccharomyces boulardii in acute childhood diarrhoea

Phase 3
Conditions
acute childhood diarrhoea
Registration Number
CTRI/2008/091/000255
Lead Sponsor
mohd mushir reyaz
Brief Summary

this is an ongoing double blinded randomized controlled clinical trial to see the efficacy and safety of Saccharomyces boulardii(250 mg BD for 3days or till recovery whichever is earlier) in acute childhood diarrhoea.it is being conducted at pediatric ward ,jnmc,amu,aligarh ,india.primary outcome variable is duration of diarrhoea .The secondary outcome variable are rehydration time,frequency of loose stool&vomiting,ORS consumed,adverse drug reaction to S.boulardii

Detailed Description

Not available

Recruitment & Eligibility

Sex
Not specified
Target Recruitment
200
Inclusion Criteria

children age 3mths-5yrs with acute diarrhoea.

Exclusion Criteria

severe malnutrition ,systemic illness,encephalopathy,convulsion,feature of immunodeficiency,use of IV antibiotics.

Study & Design

Study Type
Not specified
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
duration of diarrhoea3 consecutive semi-formed stool or no stool in last 12 hours
Secondary Outcome Measures
NameTimeMethod
rehydration time ,ORS consumed,frequency of vomiting and diarrhoea,adverse drug reaction to S.boulardii3 consecutive semiformed stool or no stool in last 12 hours

Trial Locations

Locations (1)

Pediatric ward(ward :16)

🇮🇳

Aligarh, UTTAR PRADESH, India

Pediatric ward(ward :16)
🇮🇳Aligarh, UTTAR PRADESH, India
mohd mushir reyaz
Principal investigator
09997497934
mushir_reyaz@yahoo.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.